profit from every $100 of sales.
$0$100
Dolby Laboratories
$64.66-0.02% today
-1.7% in 1 year
1-year low $48.511-year high $69.09
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $23.75 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Dolby Laboratories sold, what it kept, and what it did with the cash.
Sales went from $1.25 billion in 2022 to $1.35 billion in 2025, with $255 million of profit last year.
SalesProfit
Dolby Laboratories handed back 67% of the cash it generated last year.
Buybacks $162M$127M
Free cash flow 2025$430M
Bought back its own shares$162M
Paid as dividends$127M
Cash vs. debt$702M vs. $39M
Dolby Laboratories vs. similar companies
Dolby Laboratories grows the slowest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Dolby Laboratories | 23.7× · Fair price | ||
 IBM | 22.1× · Fair price | ||
 Accenture | 17.9× · Fair price | ||
 Tata Consultancy Services | 18.2× · Fair price | ||
 Infosys | 15.1× · Fair price |
AI analysis
An AI analyst reads Dolby Laboratories's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,162 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | |
| 1,015 | 1,151 | 1,112 | 1,147 | 1,133 | 1,189 | |
| – | – | 217 | 263 | 265 | 280 | |
| – | – | 321 | 358 | 352 | 379 | |
| 231 | 310 | 184 | 201 | 262 | 255 | |
| 2.25 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | |
| 87.4% | 89.9% | 88.7% | 88.3% | 89.0% | 88.1% | |
| – | – | 17.3% | 20.2% | 20.8% | 20.8% | |
| 19.9% | 24.2% | 14.7% | 15.4% | 20.6% | 18.9% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 2,917 | 3,106 | 2,690 | 2,980 | 3,110 | 3,228 |
| Cash | 1,072 | 1,225 | 620 | 745 | 482 | 702 |
| Total debt | – | – | 51 | 51 | 47 | 39 |
| Total liabilities | 479 | 501 | 439 | 608 | 623 | 596 |
| 2,433 | 2,598 | 2,246 | 2,355 | 2,477 | 2,623 | |
| 103 | 105 | 102 | 98 | 97 | 97 | |
| – | – | 7.5% | 8.6% | 8.3% | 8.3% | |
| 9.5% | 11.9% | 8.2% | 8.5% | 10.6% | 9.7% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 344 | 448 | 319 | 367 | 327 | 472 | |
| – | – | 59 | 30 | 30 | 42 | |
| – | – | 259 | 337 | 297 | 430 | |
| Dividends paid | 89 | 89 | 100 | 103 | 115 | 127 |
| – | – | 567 | 180 | 199 | 162 | |
| 87 | 100 | 115 | 118 | 120 | 129 |
Valuation
- 23.7×
- 15.0×
- 7.68
- 2.0×
- 4.5×
- 14.1×
- 14.2×
- 7.1%
- 4.2%
- 2.6%
Profitability
- 88.1%
- 20.8%
- 18.9%
- 27.6%
- 7.8%
- 9.6%
- 9.3%
- 7.5%
- 9.2%
- 19.5%
Growth
- +3.0%
- +3.1%
- +44.7%
- +8.9%
- −1.3%
Financial health
- -1.4×
- 0.02
- 1.5%
- 61.8×
- 2.98
- 2.91
- 0.42
How it ranks in Technology
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 45%of 974
Top 16%of 975
Top 36%of 731
Bottom 32%of 982
Top 14%of 985
What analysts expect
- Average price target
- $85.00
- Range
- $85.00 – $85.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.37 | 1.31 | +4.6% |
| Jan 29, 2026 | 1.06 | 0.99 | +6.7% |
| Nov 18, 2025 | 0.99 | 0.70 | +41.6% |
| Jul 31, 2025 | 0.78 | 0.71 | +9.2% |
| May 1, 2025 | 1.34 | 1.27 | +5.5% |
| Jan 29, 2025 | 1.14 | 1.12 | +1.8% |
| Nov 19, 2024 | 0.81 | 0.70 | +15.7% |
| Aug 7, 2024 | 0.71 | 0.31 | +132.8% |
2.6%of the share price, paid each year
On $1,000 invested$26a year at today's yield, before tax
+8.9%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.42 in 2015 → $1.35 in 2025
How safe it looks
49.6% of its profit
Room to growStretchedMore than it earns: 29.4%
News
Cognition outlines mid-2027 Phase III start in DLB and cash runway into Q4 2027Seeking Alpha · Nov 6, 2026Here’s Why Dolby Laboratories (DLB) Traded Down in Q2Yahoo Finance · Sep 17, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
72Pass
Benjamin Graham
72Pass
Philip Fisher
65Pass
Peter Lynch
26No pass
Joel Greenblatt
27No pass
Charlie Munger
63Pass
Terry Smith
58No pass
Questions about Dolby Laboratories
Is Dolby Laboratories a good stock to buy?
A solid business at a fair price. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Dolby Laboratories AI analysis
What does Dolby Laboratories do?
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. It is in Information Technology Services, based in San Francisco, CA, United States, with 2,051 employees.
Does Dolby Laboratories pay a dividend?
Yes. At today's price the dividend is 2.6% a year, about 50% of its yearly profit. In 2025 it paid out $127 million in dividends.
Is Dolby Laboratories stock halal?
Yes. Dolby Laboratories passes our halal screen: its business is permitted and its debt is 0.6% of its market value, under the 30% limit. How we check
How has Dolby Laboratories stock done over the past year?
Down 1.7% over the past twelve months, to $64.66. It traded between $48.51 and $69.09 and is 6.4% below its high.
Who are Dolby Laboratories's competitors?
The largest listed companies in the same industry are IBM, Accenture, Tata Consultancy Services and Infosys. The peers table on this page compares their profit, growth and price with Dolby Laboratories's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.